RJA
QDEL icon

Ross\Johnson & Associates’s QuidelOrtho QDEL Stock Holding History

Ross\Johnson & Associates’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16 Sell
1
-2
-67% -$49 ﹤0.01% 214
2025
Q4 		$86 Buy
3
+2
+200% +$54 ﹤0.01% 318
2025
Q3 		$29 Hold
1
– – ﹤0.01% 212
2025
Q2 		$29 Hold
1
– – ﹤0.01% 210
2025
Q1 		$35 Buy
+1
New +$41 ﹤0.01% 353

Other funds holding QDEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Ross\Johnson & Associates's QDEL Position: Q1 2026 in Review

Ross\Johnson & Associates reduced its QuidelOrtho (QDEL) stake by 67% in Q1 2026, selling an estimated $49 and leaving 1 share worth $16. The position accounts for ﹤0.01% of the portfolio, ranked #214.

Ross\Johnson & Associates first reported a position in QDEL in Q1 2025 and has held it in 5 quarters since. The position peaked at $86 in Q4 2025. 237 funds tracked by Wall St. Rank hold QDEL as of Q1 2026.

  • Ross\Johnson & Associates held 1 share of QuidelOrtho worth $16 as of Q1 2026.
  • Ross\Johnson & Associates sold 2 QuidelOrtho shares in Q1 2026, an estimated $49.
  • QuidelOrtho made up ﹤0.01% of Ross\Johnson & Associates's portfolio in Q1 2026, its #214 holding.
  • Ross\Johnson & Associates first reported a position in QuidelOrtho in Q1 2025 and has held it in 5 quarters since.
  • Ross\Johnson & Associates's QuidelOrtho position peaked at $86 in Q4 2025.
  • 237 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2026.

Based on Ross\Johnson & Associates's 13F filing for Q1 2026, filed 8 May 2026.